Abatacept monotherapy compared with abatacept plus disease-modifying anti-rheumatic drugs in rheumatoid arthritis patients: data from the ORA registry

BACKGROUND: Retention rate, efficacy, and safety of abatacept (ABA) was compared between patients with rheumatoid arthritis receiving ABA as monotherapy to those in combination ABA + conventional synthetic DMARD (csDMARD). METHODS: The patients were obtained from the ORA registry. The retention rate...

Descripción completa

Detalles Bibliográficos
Autores principales: Truchetet, Marie-Elise, Poursac, Nicolas, Barnetche, Thomas, Shipley, Emilie, Gottenberg, Jacques-Eric, Bannwarth, Bernard, Richez, Christophe, Schaeverbeke, Thierry
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4815200/
https://www.ncbi.nlm.nih.gov/pubmed/27029339
http://dx.doi.org/10.1186/s13075-016-0956-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4815200/
https://www.ncbi.nlm.nih.gov/pubmed/27029339
http://dx.doi.org/10.1186/s13075-016-0956-7

Ejemplares similares